The Legal 500

Hoffmann • Eitle

ARABELLASTRASSE 30, 81925 MÜNCHEN, GERMANY
Tel:
Work +49 89 92 40 90
Fax:
Fax +49 89 91 83 56
Email:
Web:
www.hoffmanneitle.com
Munich, London, Hamburg, Düsseldorf

Germany

Top-tier recommendations

Recommendations


Germany: Intellectual property

Within Patent litigation, Hoffmann • Eitle is a third tier firm,

Renowned prosecution firm Hoffmann • Eitle has developed ‘a recognised litigation team’ over the past decade. The firm has a strong pharmaceuticals practice, in which Niels Hölder was promoted to the partnership, and which represents Boehringer Ingelheim and GlaxoSmithKline. Medical devices litigation and the representation of German mid-cap companies are growing areas, and licensing-related litigation is another notable niche. Dirk Schüßler-Langeheine, who speaks Japanese, acts for many Japanese companies including longstanding clients Toyota Industries and Panasonic. Holger Stratmann is representing Seiko Epson in several proceedings. Several patent lawyers, including Matthias Kindler, are ‘experienced litigators’.

[back to top]

Within Patent prosecution, Hoffmann • Eitle is a first tier firm,

Hoffmann • Eitle’s ‘renowned’ practice fields 62 patent lawyers, among them 26 partners, and includes UK and Denmark qualified patent lawyers. It covers all areas, particularly chemicals, electrical engineering, IT and mechanical engineering. Its core business is the representation of Japanese companies – including Fujifilm, Mitsubishi and Fujitsu – supplemented by a significant number of clients from the US and China, as well as local clients in Hamburg and Düsseldorf. Matthias Kindler is recommended for chemical patents, as is Georg Siegert for telecoms.

[back to top]

Within Trade marks (including competition), tier 5

Renowned for its patent practice, Hoffmann • Eitle’s internationally focused team also covers registrations, administration and litigation pertaining to trade marks and registered designs, and has experienced an increase in trade mark infringement and border seizure cases. Wedig von der Osten-Sacken heads the team, which advises Inter IKEA Systems and Monster Cable on the enforcement of trade marks rights and represents Burton in infringement matters. The team also administers Weber & Ott’s global portfolios. Ortrun Günzel joined Taylor Wessing.

[back to top]


Further information on Hoffmann • Eitle

Please choose from this list to view details of what we say about Hoffmann • Eitle in other jurisdictions.

Germany

Offices in Munich, Hamburg, and Düsseldorf

Foreign firms

Legal Developments in Germany

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • GSK Advises EnBW AG on Acquisition of Eni’s Joint Venture Holdings in Gas Business

    EnBW Energie Baden-Württemberg AG (EnBW) is acquiring the 50%  holdings of Eni Gruppe, Rome, in EnBW Eni Verwaltungsgesellschaft mbH, Stuttgart, thereby increasing its holdings to 100 %. This makes EnBW indirectly the sole shareholder of Gasversorgung Süddeutschland GmbH (GVS) and terranets bw GmbH. GSK Stockmann + Kollegen provided comprehensive legal advice to EnBW in connection with this transaction.
  • GSK Advises PAMERA Real Estate Group on the Sale of the PAMERA Companies to Cornerstone Group

    GSK Stockmann + Kollegen advised the shareholder of the PAMERA Asset Management GmbH, the PAMERA Retail GmbH and the PAMERA Development GmbH on the sale of these companies to the European Cornerstone subsidiary of US-American Cornerstone Estate Advisers LLC.
  • GSK Advises GEWA 5 to 1 GmbH & Co. KG on Issuance of Real Estate Project Bond

    GSK Stockmann + Kollegen advised the GEWA 5 to 1 GmbH & Co. KG in connection with the issuance of a real estate project bond in the amount of up to € 35 million. Following the issuance by the Cloud No. 7 GmbH this is the second bond issuance for the construction of an apartment and hotel tower that GSK Stockmann + Kollegen has provided advice on.
  • GSK Update: Proposal for Uniform Protection of Trade Secrets Throughout Europe

    In the information society trade secrets are among the most important assets of any business. The quantity and quality of the trade secrets represent a substantial part of the company's assets. In the European Union there are currently varying levels of protection, insofar as trade secrets are legally protected at all. This hinders cross-border business and companies that operate internationally are faced with legal uncertainty. The EU Commission now wants to change this and has submitted a proposal for a uniform level of protection and protective system across Europe.
  • GSK Newsletter: Taxation of Cross-Border Transactions in Germany

    There are a number of ways how a foreign entity or private individual can pursue business activities in Germany. First, you can become active without creating a physical presence in Germany simply by supplying goods and services to German clients from abroad. Second, the foreign business might establish a fixed place in Germany (e.g. a permanent establishment) from which it pursues its German activities. Third, the foreign business might set up a German subsidiary either as a partnership or as a corporation. Last but not least, collective investment schemes, whose taxation regime has been extensively reorganized recently, might also be an interesting alternative for foreign investors. Which route to follow will mainly depend on the kind and the size of the business activities to be carried out in Germany or with German clients as well as on tax considerations that will have an impact on the decisions to be made. This  GSK Tax Newsletter  shall provide a first introduction to the taxation issues a foreign business considering to expand its activities to Germany will have to take into account. We would be pleased to help you with any questions in this regard!
  • GSK advises 2D Holding GmbH in connection with sale of SÜDDEKOR Group to SURTECO SE

    GSK Stockmann + Kollegen advised 2D Holding GmbH in connection with the sale of SÜDDEKOR Group, a leading specialist in surface finishing of wood materials, to SURTECO SE. On October 23, 2013, 2D Holding GmbH and SURTECO SE entered into a pur-chase agreement regarding the sale of SÜDDEKOR Group consisting of  SÜDDEKOR GmbH in Laichingen, Dakor Melamin Imprägnierungen GmbH in Her-oldstatt, SÜDDEKOR Art Design + Engraving GmbH in Willich, SÜDDEKOR LLC (USA) and Süddekor OOO (Moscow) to SURTECO SE. The transaction was suc-cessfully completed on December 2, 2013 after antitrust release had been obtained. The parties agreed to keep the purchase price confidential.
  • GSK attorneys authored the German Chapter of GTDT's 6th edition of Banking Regulation

    Getting the Deal Through has published the fully revised and updated sixth edition of Banking Regulation, a volume in the series of annual reports, which provide international analysis in key areas of law and policy for corporate counsel, cross-border legal practitioners and business people.
  • GSK attorney Karl v. Hase authored the German Chapter of GTDT’s 10th edition of Dispute Resolution

    Getting the Deal Through has published its fully revised and updated tenth edition of Dispute Resolution, a volume in the series of annual reports, which provide international analysis in key areas of law and policy for corporate counsel, cross-border legal practitioners and business people. Following the format adopted throughout the series, the same key questions are answered by leading practitioners in each of the 47 jurisdictions featured. GTDT's German Chapter was authored by GSK attorney Dr. Karl von Hase. In his article he gives an overview of civil and commercial litigation in Germany, arbitration agreements and alternative dispute resolution (ADR).
  • GSK attorneys authored the German Chapter of GTDT's 5th edition of Banking Regulation

    Getting the Deal Through has published the fully revised and updated fifth edition of Banking Regulation, a volume in the series of annual reports, which provide international analysis in key areas of law and policy for corporate counsel, cross-border legal practitioners and business people.
  • Court of Justice of the European Union renders final decision on...

    Supplementary Protection Certificates with regard to second marketing authorization of medical compounds (decision of July 19, 2012 – Case C-130/11 –Neurim Pharmaceuticals vs. Comptroller General of Patents)